“They didn’t give up on me”: a women’s transitions clinic from the perspective of re-entering women. Thomas, K. et al., Addiction Science & Clinical Practice 2019 14:12
A conceptual model for understanding post-release opioid-related overdose risk. Joudrey, P.J. et al. Addiction Science & Clinical Practice 2019 14:17
A policy guide to the state of drug law enforcement research. Mazerolle, L., International Journal of Drug Policy , Volume 41 , 164 - 165
Addressing Human Rights Abuses against People Who Use Drugs: A Critical Role for Human Rights Treaty Bodies and Special Procedures. Golichenko, M. et al. Journal of Human Rights Practice, 10, 2018, 83–102
Adolescentes infractores. Prácticas de las agencias del sistema penal juvenil. Puebla, M.D., Torti, S. & Marty, C.S. Revista Interferencia, Vol. 0 Nº 2 Año 2012
An optimal anti-drug law enforcement policy. Poret, S. International Review of Law and Economics, Volume 29, Issue 3, September 2009, Pages 221-228
Associations among Substance Use, Mental Health Disorders, and Self Harm in a Prison Population: Examining Group Risk for Suicide Attempt. International Journal of Environmental Research and Public Health. 2017 Mar 20;14(3)
Barriers to addiction treatment among formerly incarcerated adults with substance use disorders. Owens, M.D. et al, Addiction Science & Clinical Practice 2018 13:19
Cannabis for personal use in the Supreme Court of Mexico: Legal case and potential for policy change. Aguinacoa, A. & Barrab A. International Journal of Drug Policy Volume 50, December 2017, Pages 9-10
Challenges and mental health needs of women in prison. Bartlett, A., & Hollins, S. The British Journal of Psychiatry, 212(3), 134-136
Depenalization, diversion and decriminalization: A realist review and programme theory of alternatives to criminalization for simple drug possession. Stevens, A., Hughes, C. E., Hulme, S., & Cassidy, R. (2019) European Journal of Criminology.
Do law enforcement interactions reduce the initiation of injection drug use? An investigation in three North American settings. Melo, J.S. et al. Drug Alcohol Depend. 2018 Jan 1;182:67-73
Establishing a ‘Corstonian’ continuous care pathway for drug using female prisoners: Linking drug recovery wings and women’s community services.. Grace S., Page G., Lloyd C., et al. Criminology and Criminal Justice: 2016, 16(5), p. 602–621
Justicia Restaurativa en Sistemas de Justicia Penal Juvenil Comparado: Suecia, Inglaterra, Italia y Chile. Reyes-Quilodrán, C. & LaBrenz, C.A. Polít. crim. vol.13 no.25 Santiago jul. 2018
Light and heavy drinking in jurisdictions with different alcohol policy environments. Foster, S. et al. International Journal of Drug Policy, Volume 65, March 2019, Pages 86-96
Prisión preventiva en América Latina: El impacto desproporcionado en mujeres privadas de libertad por delitos de drogas. García-Castro, T. Informe mujeres, políticas de drogas y encarcelamiento, WOLA, IDPC, Dejusticia (2019)
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons. Duke, K., International Journal of Drug Policy, Available online 31 May 2019
Protocol for a randomized controlled trial of the Breaking Free Online Health and Justice program for substance misuse in prison settings. Elison-Davies, S. et al. Health Justice. 2018 Nov 3;6(1):20
Tensions and contradictions in family court innovation with high risk parents: The place of family drug treatment courts in contemporary family justice. Harwin, J. et al. International Journal of Drug Policy, Volume 68, June 2019, Pages 101-108
The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overview. Comber, R. et al. International Journal of Drug Policy Volume 58, August 2018, Pages 93-103
The Perfect Storm: COVID-19, mass incarceration and the opioid epidemic. Mukherjeea, T.I. & El-Basselb, N. International Journal of Drug Polic Available online 11 June 2020, 102819
Transnational social movement theory and the waning war on drugs: Case studies from UNGASS 2016. Mostyn, B., Gibbon, H,. Int J Drug Policy. 2018 Jan;51:148-155
